1. Home >
  2. Companies >
  3. Life Science >
  4. United States >
  5. New York >
  6. Acorda Therapeutics

Acorda Therapeutics - M&A Summary and Business Overview

Life ScienceCompany

Acorda Therapeutics M&A Summary

Acorda Therapeutics has acquired 4 companies. A total of 1 acquisition came from private equity firms. It has also divested 2 assets.

Acorda Therapeutics’ largest acquisition to date was in 2014, when it acquired Civitas Therapeutics for $525M. Acorda Therapeutics has acquired in 3 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).

Acorda Therapeutics Business Overview

Where is Acorda Therapeutics headquartered?

Acorda Therapeutics is headquartered in Pearl River, New York.

What is Acorda Therapeutics’ revenue?

Acorda Therapeutics disclosed revenue of 118M USD for 2023 and 119M USD for 2022.

How many employees does Acorda Therapeutics have?

Acorda Therapeutics has 102 employees.

What sector is Acorda Therapeutics in?

Acorda Therapeutics is a life science company.

When was Acorda Therapeutics founded?

Acorda Therapeutics was founded in 1995.

M&A Summary

  • M&A Total Activity6
    • M&A Buy Activity4
    • M&A Sell Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 3
  • M&A Advisors 8

Acorda Therapeutics

Acorda Therapeutics, Inc.

2 Blue Hill Plaza, 3rd Floor,
Pearl River, New York 10965
United States,
(914) 347-4300
www.acorda.com

Acorda Therapeutics is a biotechnology company developing therapies for multiple sclerosis and related neurological conditions such as spinal cord injury (SCI). Acorda Therapeutics was founded in 1995 and is headquartered in Pearl River, New York.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # 4 - - - - - 4
vol $988M $988M
Sell (0.2/yr) # 1 1 - - - - 2
  6

Most Recent M&A

Company Date Value Type
Acorda Therapeutics, Inc. - Manufacturing & Packaging Operations 2021-01-13 - Divestiture
Chelsea, Massachusetts
Acorda Therapeutics, Inc. - Qutenza 2018-11-05 - Divestiture
Ardsley, New York · www.qutenza.com
Biotie Therapies Corp. 2016-01-19 363M USD Add-on Acquisition
Turku, Finland · www.biotie.com
Civitas Therapeutics, Inc. 2014-09-24 525M USD Add-on Acquisition
Chelsea, Massachusetts · www.civitastherapeutics.com
NeurogesX, Inc. 2013-07-09 - Add-on Acquisition
San Mateo, California · www.neurogesx.com
Neuronex, Inc. 2012-02-20 100M USD Add-on Acquisition
Morrisville, North Carolina · www.neuronexinc.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 4 (100%) 988M (100%) - -
Manufacturing - - 1 (50%) -
Medical Products - - 1 (50%) -
Total 4 $988M 2 -

By Geo

State/Country Buy Value Sell Value
United States 3 625M 2 -
  Massachusetts 1 525M 1 -
  North Carolina 1 100M - -
  California 1 - - -
  New York - - 1 -
Finland 1 363M - -
Domestic 3 (75%) 625M (63%) 2 (100%) -
Cross-border 1 (25%) 363M (37%) - -
Total 4 $988M 2 -

Top M&A Advisors

Financial Deals
Lazard
 2
MTS Health Partners
 2
J.P. Morgan Securities
 1
Legal Deals
Covington & Burling
 1
Cadwalader, Wickersham & Taft
 1
Kirkland & Ellis
 1

Deal Values

buy # Total
$100M to $1B 2 $888M
< $100M 1 $100M
TOTAL $988M
Largest Civitas Therapeutics, Inc.
$525M (2014-09-24)

M&A Connections

Deals
Acquired from
Investor(s)
25%
1 (25%)
Divested to
Strategic(s)
100%
2 (100%)

Company Summary

SECTOR

Life Science

Revenue

118   1% 2023
119   8% 2022
129   16% 2021
153   21% 2020
192   60% 2019
471   20% 2018
588   14% 2017
520   6% 2016
493   23% 2015
401   20% 2014
336   11% 2013
305   2012
(millions of USD) Show More Show Less

Employees

102

Established

1995

Public

ACORQ

Try Mergr Free — See This and 215,318+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 209K M&A Transactions
  • 211K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Acorda Therapeutics

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies
Mergr

Solution for

Product

Company

Legal